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Epithelial tumors of the thymic gland are rare malignancies,mostly with an indolent behavior. Their biology is largely
unknown and several pathologic classifications have been
introduced in trying to better define the characteristics and the
prognosis of this tumor. Surgery is the mainstay treatment
and it may suffice in earlier stages; however, many patients
present with advanced stage and then require aggressive
multimodality treatment. The more aggressive histologic
types, such as thymic carcinomas, are often not cured by
surgery. Furthermore, the association of these tumors with a
broad array of paraneoplastic and autoimmune diseases make
them unique. Drug development for the treatment of ad-
vanced disease is difficult because of the rarity of the disease
and the lack of knowledge of the biology. Ethnical differ-
ences are also important and starting to become apparent,
with more aggressive histologic types being observed in
Asians and African Americans.
This monograph of the Journal of Thoracic Oncology
includes all major presentations given during the first Inter-
national Conference on Thymic Malignancies held on August
20–21, 2009, on the campus of the National Institutes of
Health in Bethesda, MD. The meeting was cosponsored by
the Medical Oncology Branch of the National Cancer Insti-
tute, National Institutes of Health, and the Foundation for
Thymic Cancer Research (an organization established to
increase awareness about this rare disease and who sponsor
meetings and research in this area). More than 100 partici-
pants from major institutions in the United States, Europe,
and Japan that have an interest in studying the disease and
have expertise in its treatment attended the meeting. During
the 2-day meeting, extensive reviews were given, which
spanned from epidemiology to biology of the disease to
treatment and research. Several important and novel contri-
butions to research were presented at the meeting.
After this conference, efforts were made to create an
association that would study this disease in a structured
fashion. A meeting to ratify this structure, called Interna-
tional Thymic Malignancy Interest Group was held in New
York City on May 5–6, 2010. Information about this
important new association and its scope are also included
in this monograph.
Similar to many rare malignancies that have been
largely understudied, I hope that this monograph will draw
attention to this fascinating tumor in which research,
treatment of patients, and centers with this expertise is
exceedingly warranted.
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